Overcoming the cardiac toxicities of cancer therapy immune checkpoint inhibitors

Immune checkpoint inhibitors (ICIs) have led recent advances in the field of cancer immunotherapy improving overall survival in multiple malignancies with abysmal prognoses prior to their introduction. The remarkable efficacy of ICIs is however limited by their potential for systemic and organ speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Irabor, Omoruyi Credit, Nelson, Nicolas, Shah, Yash, Niazi, Muneeb Khan, Poiset, Spencer, Storozynsky, Eugene, Singla, Dinender K., Hooper, Douglas Craig, Lu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523689/
https://www.ncbi.nlm.nih.gov/pubmed/36185227
http://dx.doi.org/10.3389/fonc.2022.940127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523689/
https://www.ncbi.nlm.nih.gov/pubmed/36185227
http://dx.doi.org/10.3389/fonc.2022.940127

Ejemplares similares